| Literature DB >> 31717848 |
Alessandro Tonacci1, Lucia Billeci1, Elisa Burrai2, Francesco Sansone1, Raffaele Conte1.
Abstract
Psychological stress is known to activate the autonomic nervous system (ANS), thus representing a useful target to be monitored to understand the physiological, unconscious effect of stress on the human body. However, little is known about how differently the ANS responds to cognitive and sensory stimulations in healthy subjects. To this extent, we enrolled 23 subjects and administered a stress protocol consisting of the administration of sensory (olfactory) and cognitive (mathematical) stressors. Autonomic parameters were unobtrusively monitored through wearable sensors for capturing electrocardiogram and skin conductance signals. The results obtained demonstrated an increase of the heart rate during both stress protocols, with a similar decrease of the heart rate variability. Cognitive stress test appears to affect the autonomic parameters to a greater extent, confirming its effects on the human body. However, olfactory stimulation could be useful to study stress in specific experimental settings when the administration of complex cognitive testing is not feasible.Entities:
Keywords: ECG; autonomic nervous system; olfaction; skin response; stress
Mesh:
Year: 2019 PMID: 31717848 PMCID: PMC6864789 DOI: 10.3390/s19214661
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Time- and frequency-domain features extracted from the ECG signal.
|
| ||
|
|
|
|
| Heart rate | HR | Number of heart pounds per time unit, expressed in bpm. The HR is normally related to the SNS activation of the ANS |
| Standard deviation of normal-to-normal R–R intervals | SDNN | Measure of heart rate variability (HRV), expressed in ms. The SDNN is normally affected by both SNS and PNS components, but largely depends on testing conditions, with the PNS activity being predominant during short-term resting recordings [ |
| Changes in successive normal sinus (NN) intervals exceeding 50 ms | pNN50 | Measure of HRV, expressed as a percentage. Overall, pNN50 is closely correlated to the PNS activity [ |
| Cardiac sympathetic index | CSI | Measure of SNS activity derived from the Lorenz plot analysis [ |
|
| ||
|
|
|
|
| Normalized component of the power spectral density of the ECG signal at low frequency (0.04–0.15 Hz) | nLF | nLF is related to both SNS and PNS activity, though, in resting conditions, the LF band reflects baroreflex activity (see [ |
| Normalized component of the power spectral density of the ECG spectrum at high frequency (0.15–0.4 Hz) | nHF | nHF is related to PNS activity, though its direct relationship with the vagal tone is not always evident |
| Low-to-high frequency component of the power spectral density of the ECG spectrum | LF/HF | To a first approximation, LF/HF ratio is considered a marker of the balance between SNS and PNS activity, despite this assumption is not necessarily true, especially during short, resting recordings, where, as stated, the LF often reflects baroreflex activity |
Autonomic parameters in the different phases indicated as mean ± standard deviation (B: Baseline, T I: Task I, T II: Task II, T III: Task III, R: Recovery; N/A: Post hoc comparison not performed due to nonsignificance of the Friedman’s test; *: p < 0.05, **: p < 0.01).
| Feature | Baseline | Task I | Task II | Task III | Recovery | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| HR, bpm | 75.7 ± 10.6 | 77.1 ± 9.4 | 81.1 ± 11.8 | 76.3 ± 8.7 | 74.9 ± 9.4 | <0.001 ** | 0.040 * | 0.003 ** | <0.001 ** | 0.014 * |
| SDNN, ms | 74.1 ± 28.4 | 79.0 ± 28.0 | 62.5 ± 28.3 | 82.8 ± 31.7 | 74.2 ± 31.4 | <0.001 ** | 0.094 | <0.001 ** | <0.001 ** | 0.016 * |
| pNN50, % | 22.3 ± 16.6 | 19.8 ± 14.4 | 14.4 ± 13.0 | 20.9 ± 14.1 | 18.4 ± 14.3 | <0.001 ** | 0.077 | 0.001 ** | <0.001 ** | 0.021 * |
| CSI, ratio | 2.95 ± 0.72 | 3.19 ± 0.73 | 3.29 ± 1.18 | 3.11 ± 0.66 | 3.18 ± 0.70 | 0.352 | N/A | N/A | N/A | N/A |
| nLF, n.u. | 0.67 ± 0.16 | 0.71 ± 0.13 | 0.67 ± 0.11 | 0.75 ± 0.10 | 0.68 ± 0.14 | <0.001 ** | 0.465 | 0.117 | 0.001 ** | 0.005 ** |
| nHF, n.u. | 0.33 ± 0.16 | 0.29 ± 0.13 | 0.33 ± 0.11 | 0.25 ± 0.10 | 0.32 ± 0.14 | <0.001 ** | 0.465 | 0.117 | 0.001 ** | 0.005 ** |
| LF/HF, ratio | 2.69 ± 1.54 | 3.26 ± 2.20 | 2.61 ± 1.84 | 3.82 ± 2.41 | 3.02 ± 2.46 | <0.001 ** | 0.563 | 0.068 | 0.001 ** | 0.012 * |
| GSR Tonic, µS | 3.46 ± 2.90 | 4.92 ± 4.93 | 5.93 ± 4.68 | 6.73 ± 5.18 | 6.53 ± 5.36 | <0.001 ** | <0.001 ** | <0.001 ** | 0.001 ** | 0.031 * |
Figure 1Significant ECG data across the test phases: (a) HR, (b) SDNN, (c) pNN50, (d) nLF, (e) nHF, (f) LF/HF. *: p < 0.05, **: p < 0.01.
Figure 2GSR tonic value across the test phases. *: p < 0.05, **: p < 0.01.
Figure 3Correlation between TSST trial count and pNN50 during the task.